Ester Mejstríková

Title: **Ester Mejstríková: Innovator in Flow Cytometry and Minimal Residual Disease Diagnostics**

Introduction

Ester Mejstríková is a prominent inventor based in Prague, Czech Republic, known for her significant contributions to the fields of flow cytometry and minimal residual disease diagnostics. With a total of four patents to her name, she has advanced the techniques used for analyzing leukocyte populations and improving diagnostic methods for hematological malignancies.

Latest Patents

Among her latest innovations is the patent titled "Methods, reagents and kits for flow cytometric immunophenotyping." This invention relates specifically to flow cytometry and introduces a panel of antibody reagents conjugated to fluorescent compounds. Her reagent compositions include at least eight distinct fluorochrome-conjugated antibodies designed for the identification of leukocyte populations and their further characterization.

Another notable patent is "Methods, reagents and kits for detecting minimal residual disease." This invention is essential for MRD diagnostics, especially in evaluating treatment effectiveness for conditions such as B-cell precursor acute lymphoblastic leukemia, B-cell chronic lymphocytic leukemia, and multiple myeloma. Her formulations allow for advanced staining techniques that can detect minimal residual disease with exceptional sensitivity.

Career Highlights

Ester Mejstríková currently works at Erasmus University Medical Center Rotterdam, where she collaborates with fellow experts in the field to develop innovative diagnostic solutions. Her work is pivotal in enhancing the understanding and treatment outcomes of various hematological conditions through advanced flow cytometry techniques.

Collaborations

Throughout her career, Ester has collaborated with notable professionals such as Jacobus Johannes Maria van Dongen and José Alberto Orfao de Matos Correia e Vale. These collaborations have fostered significant advancements in her research and inventions, contributing to her reputation as an innovator in her industry.

Conclusion

Ester Mejstríková stands out as a leading inventor in the realm of flow cytometry and minimal residual disease diagnostics. Her innovative patents reflect her dedication to enhancing medical research and patient care, paving the way for future advancements in the diagnosis and treatment of hematological diseases.